Target intelligence / Profile preview

tripartite motif containing 60 pseudogene 7, Y-linked (TRIM60P7Y)

Target
TRIM60P7Y
Molecular classification
Other (Pseudogene), Pseudogene
01

Overview

TRIM60P7Y (tripartite motif containing 60 pseudogene 7, Y-linked) is a pseudogene member of the tripartite motif-containing family, annotated under various aliases including TRIM60P7 and TRIM60PY7[1][5][7][8]. As a pseudogene, TRIM60P7Y does not code for a functional protein, and there is no evidence in current scientific or clinical databases to support its involvement in therapeutic processes, disease roles, or as a drug target[8]. Pseudogenes can, in some cases, modulate biological pathways through non-coding RNA mechanisms, such as acting as microRNA decoys, but there is no specific literature or experimental data indicating such a function for TRIM60P7Y[2][4]. Consequently, it is not considered a receptor, enzyme, or therapeutic target. While functional TRIM proteins (not pseudogenes) are often involved in E3 ubiquitin ligase activity, immune responses, and other key regulatory functions[9][10], TRIM60P7Y is not among them, as it is a pseudogene lacking functional protein expression. Some pseudogenes regulate gene expression by acting as miRNA decoys or antisense RNAs[2][4], but again, no evidence supports this for TRIM60P7Y specifically. TRIM60P7Y is a non-coding, Y-linked pseudogene, does not produce a functional protein, is not a recognized drug target, and has no established role in health or disease pathways[1][7][8][5]. There is nothing to suggest it is a valid therapeutic target, and listing it as such would be incorrect.

Other names
TRIM60P7TRIM60PY7TRIM60P7Y

Beyond the preview

Go deeper on tripartite motif containing 60 pseudogene 7, Y-linked (TRIM60P7Y).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tripartite motif containing 60 pseudogene 7, Y-linked (TRIM60P7Y).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call